Live Breaking News & Updates on Novel Therapeutic Strategy

Stay updated with breaking news from Novel therapeutic strategy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Molecule Associated With Poor Survival After Heart Attack Is Detected


Molecule Associated With Poor Survival After Heart Attack – Detected
by Karishma Abhishek on 
March 14, 2021 at 7:08 AM
Heart failure is one of the
deadly heart diseases, affecting 6.2 million Americans and mandates new therapies. It is an incurable disease with a staggering mortality rate of 40% within five years of diagnosis.
Reducing the levels of a heart molecule, G protein-coupled receptor kinase 5 (GRK5) may promise a novel therapeutic strategy against heart failure as per a study at the Lewis Katz School of Medicine (LKSOM) at Temple University in new work, published in the journal
Cardiovascular Research.
Previous studies had found that GRK5 is elevated in patients with heart failure. Our new research, in mice that experienced a myocardial infarction (heart attack), shows that GRK5 overexpression is associated with physiological changes in the heart that decrease cardiac function , says Claudio de Lucia, MD, Ph.D ....

Heart Disease , Heart Failure , Heart Molecule , Myocardial Infarction , G Protein Coupled Receptor Kinase 5 , Novel Therapeutic Strategy , இதயம் நோய் , இதயம் தோல்வி , இதயம் மூலக்கூறு , நாவல் சிகிச்சை மூலோபாயம் ,